Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. – Cost Effective Supplements

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.

Quick navigation

Link
Conclusion
Supplements
Functions
Systems

Link to full study

http://www.ncbi.nlm.nih.gov/pubmed/11569700

Conclusion of this study

Betaine is a safe and well tolerated drug that leads to a significant biochemical and histological improvement in patients with NASH. This novel agent deserves further evaluation in a randomized, placebo-controlled trial.

Supplements analyzed in this study

TMG

Health conditions analyzed in this study

Fatty Liver Disease

Slightly Positive

TMG

Liver Damage

Slightly Positive

TMG

Functions related to this study

Detox

Slightly Positive

TMG

Body systems related to this study

Digestive System

TMG